- Revenue
- $0.2M
- Op. margin
- −11,729.8%
- FCF margin
- −11,327.5%
Companies
Search, filter and compare every US company we cover.
Sector
All sectors
No matches for “”.
Industry
All industries
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Health Care
Industrials
Information Technology
Materials
Real Estate
Utilities
No matches for “”.
Size
Any size
No matches for “”.
Today
Up or down
No matches for “”.
Add filter
Size
Growth
Margins
Returns
Debt and payouts
Valuation and quality
Insiders
No matches for “”.
Market cap
Price
Day change
Revenue
Revenue growth
Operating margin
P/E
5-yr growth
Gross margin
Net margin
Free cash flow
FCF margin
Return on capital
Return on equity
Net debt
Net debt / EBITDA
Dividends + buybacks
Share count change
F-score
Insider buys (90d)
Insider sales (90d)
| Company | Industry | Market cap | Price | Day change | Revenue | Revenue growth | Operating margin | P/E | 5-yr growth | Gross margin | Net margin | Free cash flow | FCF margin | Return on capital | Return on equity | Net debt | Net debt / EBITDA | Dividends + buybacks | Share count change | F-score | Insider buys (90d) | Insider sales (90d) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services-Computer Programming Services | $1.9M | $0.41 | 7.0% | $0.2M | −40.5% | −11,729.8% | — | 40.6% | 38.0% | −10,716.6% | −$24.8M | −11,327.5% | — | −124.5% | — | — | — | 34,297.7% | 3 | $0.0M | $0.0M | |
| Wholesale-Metals Service Centers & Of Fices | $1.8M | $2.22 | 2.2% | $46.7M | 40.1% | −42.5% | — | 481.8% | 25.4% | −46.3% | — | — | −41.2% | −68.7% | $12.1M | — | — | 453.2% | 2 | $8.0M | $0.0M | |
| Pharmaceutical Preparations | $1.8M | $2.24 | 5.5% | $11.5M | −1.5% | −398.8% | 0.0x | 4.2% | 67.2% | −465.4% | — | — | — | — | — | — | — | 692.0% | 2 | $0.0M | $0.0M | |
| Services-Computer Programming, Data Processing, Etc. | $1.8M | $2.22 | 2.3% | $5.1M | 271.4% | −160.8% | — | — | 29.4% | −167.0% | −$7.2M | −142.8% | — | −238.9% | — | — | — | 29.3% | 4 | $0.0M | $0.0M | |
| In Vitro & In Vivo Diagnostic Substances | $1.7M | $0.19 | 3.6% | $1.7M | 40.0% | −1,258.5% | — | 164.3% | — | −1,352.1% | −$19.8M | −1,144.7% | — | — | $5.6M | — | — | 23.5% | 2 | $0.0M | $0.0M | |
| Finance Services | $1.7M | $0.33 | 53.4% | $1.5M | −9.7% | −104.2% | — | −10.9% | — | −72.1% | — | — | — | −6.6% | — | — | — | 0.0% | 3 | $0.0M | $0.0M | |
| Services-Educational Services | $1.7M | $6.10 | 1.5% | $3.6M | 37.3% | −47.6% | — | — | 45.4% | −41.2% | −$0.6M | −17.3% | — | −10.9% | — | — | — | 124.7% | 2 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.6M | $0.37 | 8.2% | — | — | — | 0.3x | — | — | — | — | — | — | −243.9% | — | — | — | 877.4% | — | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.6M | $1.67 | 2.1% | — | — | — | — | — | — | — | −$19.5M | — | — | −833.5% | — | — | — | 5,373.8% | — | $0.0M | $0.0M | |
| Surgical & Medical Instruments & Apparatus | $1.6M | $0.62 | 8.1% | $6.8M | 4.7% | −105.8% | 0.0x | 45.8% | 99.6% | −340.9% | −$7.1M | −103.2% | −94.7% | −235.5% | −$1.2M | — | — | 4,584.0% | 5 | $0.0M | $0.0M | |
| Surgical & Medical Instruments & Apparatus | $1.6M | $2.21 | 3.3% | $7.7M | 107.3% | −378.2% | 0.1x | 54.5% | 3.3% | −433.0% | −$19.2M | −249.6% | — | −337.4% | — | — | — | 145.2% | 5 | $0.1M | $0.0M | |
| Pharmaceutical Preparations | $1.6M | $4.55 | 0.9% | $62.9M | 699.0% | −338.7% | — | — | — | −325.3% | — | — | — | −53.2% | −$476M | — | — | 27.0% | 3 | $0.0M | $0.7M | |
| Pharmaceutical Preparations | $1.5M | $1.28 | 14.7% | — | — | — | 0.0x | — | — | — | — | — | — | −234.6% | — | — | — | 39,337.5% | — | $0.0M | $0.0M | |
| Services-Computer Integrated Systems Design | $1.5M | $0.10 | 2.8% | $4.4M | — | −181.0% | — | −37.4% | −29.9% | −361.4% | −$7.3M | −166.8% | — | — | — | — | — | — | — | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.5M | $1.14 | 3.6% | $0.1M | −97.9% | −24,285.1% | 0.0x | −57.9% | 19.9% | −14,685.8% | −$13.4M | −24,707.7% | −136.4% | — | $4.9M | — | — | 116.3% | 2 | $0.0M | $0.0M | |
| Services-Computer Integrated Systems Design | $1.5M | $1.07 | 2.9% | $5.8M | 3,261.0% | −179.2% | 0.0x | — | 46.0% | −632.6% | −$13.9M | −239.8% | −898.5% | — | $0.7M | — | $5.0M | 69.7% | 4 | $0.0M | $0.1M | |
| Services-Educational Services | $1.5M | $2.65 | 1.1% | $109M | −19.6% | −15.0% | 0.1x | 14.8% | 30.8% | −21.8% | −$3.4M | −3.1% | −47.4% | — | $26.1M | — | — | 93.4% | 4 | $0.0M | $0.0M | |
| Services-Health Services | $1.5M | $1.50 | 9.5% | $1.5M | 15.2% | −213.6% | 1.2x | −15.1% | 55.0% | −149.6% | — | — | — | −18.7% | — | — | — | 929.7% | 2 | $0.0M | $0.0M | |
| Perfumes, Cosmetics & Other Toilet Preparations | $1.5M | $0.37 | 1.4% | $19.2M | −1.5% | −11.3% | — | −14.5% | 62.4% | −10.6% | −$1.6M | −8.5% | — | −44.4% | — | — | — | 646.2% | 5 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.5M | $2.64 | 7.7% | $0.0M | — | −40,865.6% | 3.5x | — | 80.7% | −39,655.5% | — | — | — | −738.8% | — | — | — | 20.3% | 2 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.4M | $1.29 | 11.2% | $0.1M | 0.0% | −5,937.2% | 0.7x | 12.0% | 38.6% | −5,863.7% | — | — | — | −74.6% | — | — | — | 127.8% | 2 | $0.0M | $0.0M | |
| Real Estate Investment Trusts | $1.4M | $0.28 | 16.9% | $99.4M | −4.9% | 43.5% | 0.0x | 10.3% | — | 8.8% | — | — | — | — | — | — | $6.6M | 106,800.0% | — | $0.0M | $0.0M | |
| Insurance Agents, Brokers & Service | $1.3M | $2.20 | 1.3% | $12.4M | −11.6% | −72.5% | 0.1x | 11.2% | — | −56.2% | −$3.1M | −25.0% | −69.3% | −148.3% | $3.8M | — | $0.4M | 441.4% | 5 | $0.0M | $0.1M | |
| Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics | $1.3M | $2.25 | 2.7% | $2.5M | 6.0% | −956.5% | — | — | 94.4% | −965.0% | −$0.0M | −0.1% | — | −885.8% | — | — | — | 17.8% | 4 | $0.0M | $0.0M | |
| Air Transportation, Nonscheduled | $1.2M | $0.92 | 8.4% | $9.2M | −34.5% | −109.7% | 0.0x | — | −3.3% | 50.0% | — | — | — | 32.2% | — | — | — | 4,830.7% | 3 | $0.0M | $0.0M | |
| Services-Commercial Physical & Biological Research | $1.2M | $0.87 | 3.8% | $1.9M | −79.2% | −465.4% | 0.0x | −25.1% | 11.2% | −543.7% | −$4.2M | −219.9% | — | −327.8% | — | — | — | 547.4% | 3 | $0.0M | $0.0M | |
| Retail-Miscellaneous Retail | $1.2M | $18.01 | 0.2% | $1.4B | 7.9% | 14.4% | 9.3x | 5.3% | 60.6% | 7.4% | $114M | 8.0% | — | — | $1.2B | 4.4x | — | 1.2% | 7 | $0.0M | $0.1M | |
| Surgical & Medical Instruments & Apparatus | $1.2M | $0.58 | 3.0% | — | — | — | 0.7x | — | — | — | −$6.2M | — | — | −117.0% | — | — | — | 880.3% | — | $0.0M | $0.0M | |
| Wholesale-Metals & Minerals (No Petroleum) | $1.1M | $1.12 | 6.7% | — | — | — | — | — | — | — | — | — | — | −56.0% | — | — | — | 217.2% | — | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.1M | $0.47 | 18.9% | $0.8M | −67.7% | −2,190.0% | 0.0x | — | 77.6% | −1,720.9% | — | — | — | −115.5% | — | — | — | 2,803.1% | 4 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $1.0M | $2.24 | 22.2% | $17.9B | −22.4% | −16.3% | — | 257.2% | 35.3% | −20.6% | −$5.3B | −29.8% | −7.2% | −7.2% | −$24.3B | — | — | 3,179.9% | 3 | $0.0M | $0.0M | |
| Electronic & Other Electrical Equipment (No Computer Equip) | $1.0M | $0.26 | 38.0% | $3.0M | 51.6% | −88.0% | — | — | 6.2% | −104.0% | −$1.7M | −56.8% | −18.4% | −401.0% | $5.7M | — | — | 591.5% | 4 | $0.0M | $0.0M | |
| Electromedical & Electrotherapeutic Apparatus | $1.0M | $5.41 | 74.7% | $8.3M | −5.4% | −134.3% | 0.0x | 2.1% | 62.0% | −211.9% | −$10.9M | −131.8% | — | −382.9% | — | — | — | 2,083.9% | 2 | $0.0M | $0.0M | |
| Sporting & Athletic Goods, Nec | $1.0M | $0.80 | 7.2% | $18.9M | −13.6% | −32.3% | — | — | 50.4% | −80.7% | −$1.9M | −10.1% | — | — | −$8.2M | — | — | 1,171.7% | 3 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $0.9M | $0.66 | 3.1% | — | — | — | 0.0x | — | — | — | — | — | — | −752.2% | −$4.9M | — | — | 514.3% | 1 | $0.0M | $0.0M | |
| Services-Miscellaneous Amusement & Recreation | $0.9M | $1.14 | 0.9% | $15.3M | −31.5% | −44.5% | — | — | 50.2% | −56.2% | — | — | — | −6.5% | — | — | — | 11,573.5% | 4 | $0.0M | $0.0M | |
| Miscellaneous Electrical Machinery, Equipment & Supplies | $0.9M | $0.18 | 21.2% | $0.0M | −100.0% | — | 0.0x | — | — | — | −$20.8M | — | −126.4% | — | $26.7M | — | — | 2,628.0% | 4 | $0.0M | $0.0M | |
| State Commercial Banks | $0.9M | $51.22 | 0.6% | $254M | 8.1% | — | 14.5x | 3.6% | — | 24.2% | $80.0M | 31.5% | — | 11.7% | −$480M | — | $17.1M | 0.8% | 5 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $0.9M | $0.40 | 6.7% | $9.4M | −13.4% | −60.5% | 0.0x | −2.7% | — | −80.3% | — | — | −1,125.5% | — | −$5.1M | — | — | 108.7% | 3 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $0.8M | $0.25 | 8.2% | $0.1M | — | −16,726.7% | — | — | — | −6,851.0% | −$5.3M | −10,171.9% | — | — | — | — | — | 62.9% | — | $0.0M | $0.0M | |
| Wholesale-Lumber & Other Construction Materials | $0.8M | $0.79 | 9.5% | $3.0M | −40.7% | −476.5% | 0.0x | −19.5% | −145.3% | −637.4% | — | — | −65.8% | — | $9.3M | — | — | 3,250.0% | 3 | $0.0M | $0.0M | |
| Finance Services | $0.8M | $0.12 | 23.2% | $7.7M | −49.7% | −70.4% | — | — | — | −28.2% | — | — | — | — | — | — | — | 5.4% | 2 | $0.0M | $0.0M | |
| Biological Products, (No Diagnostic Substances) | $0.8M | $0.15 | 1.1% | $0.1M | −9.0% | −8,768.7% | — | — | 100.0% | −10,567.2% | −$10.8M | −8,264.9% | — | −294.8% | — | — | — | 76.8% | 3 | $0.0M | $0.0M | |
| Electronic Components & Accessories | $0.8M | $58.98 | 9.0% | $307M | 0.2% | 4.5% | 196.6x | 2.6% | 38.9% | 1.7% | $6.4M | 2.1% | 3.3% | 1.6% | −$66.8M | −2.2x | $0.0M | −0.5% | 6 | $0.0M | $0.0M | |
| Pharmaceutical Preparations | $0.8M | $1.15 | 0.0% | — | — | — | — | — | — | — | — | — | −20.2% | −33.0% | $42.0M | — | — | 3.2% | 1 | $0.0M | $0.0M | |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies | $0.7M | $1.29 | 2.4% | — | — | — | — | — | — | — | — | — | — | — | −$6.2M | — | — | −79.5% | — | $0.0M | $0.0M | |
| Services-Prepackaged Software | $0.7M | $3.90 | 2.0% | $241M | 6.1% | 7.5% | 36.1x | — | 77.5% | 8.3% | $32.3M | 13.4% | — | 8.2% | — | — | $59.1M | −3.7% | 7 | $0.0M | $1.2M | |
| Surgical & Medical Instruments & Apparatus | $0.7M | $0.01 | 24.9% | — | — | — | — | — | — | — | −$14.6M | — | — | −987.3% | — | — | — | 26.5% | — | $0.0M | $0.0M | |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies | $0.7M | $0.37 | 2.4% | — | — | — | — | — | — | — | — | — | — | −70.2% | — | — | — | 364.4% | — | $0.0M | $0.0M | |
| Retail-Apparel & Accessory Stores | $0.7M | $1.00 | 14.6% | $7.4M | −36.1% | −400.1% | 0.1x | 7.1% | 14.3% | −382.8% | — | — | −180.1% | −759.5% | $4.2M | — | — | 8,066.6% | 4 | $0.0M | $0.0M |
- Revenue
- $46.7M
- Op. margin
- −42.5%
- FCF margin
- —
- Revenue
- $11.5M
- Op. margin
- −398.8%
- FCF margin
- —
- Revenue
- $5.1M
- Op. margin
- −160.8%
- FCF margin
- −142.8%
- Revenue
- $1.7M
- Op. margin
- −1,258.5%
- FCF margin
- −1,144.7%
- Revenue
- $1.5M
- Op. margin
- −104.2%
- FCF margin
- —
- Revenue
- $3.6M
- Op. margin
- −47.6%
- FCF margin
- −17.3%
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $6.8M
- Op. margin
- −105.8%
- FCF margin
- −103.2%
- Revenue
- $7.7M
- Op. margin
- −378.2%
- FCF margin
- −249.6%
- Revenue
- $62.9M
- Op. margin
- −338.7%
- FCF margin
- —
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $4.4M
- Op. margin
- −181.0%
- FCF margin
- −166.8%
- Revenue
- $0.1M
- Op. margin
- −24,285.1%
- FCF margin
- −24,707.7%
- Revenue
- $5.8M
- Op. margin
- −179.2%
- FCF margin
- −239.8%
- Revenue
- $109M
- Op. margin
- −15.0%
- FCF margin
- −3.1%
- Revenue
- $1.5M
- Op. margin
- −213.6%
- FCF margin
- —
- Revenue
- $19.2M
- Op. margin
- −11.3%
- FCF margin
- −8.5%
- Revenue
- $0.0M
- Op. margin
- −40,865.6%
- FCF margin
- —
- Revenue
- $0.1M
- Op. margin
- −5,937.2%
- FCF margin
- —
- Revenue
- $99.4M
- Op. margin
- 43.5%
- FCF margin
- —
- Revenue
- $12.4M
- Op. margin
- −72.5%
- FCF margin
- −25.0%
- Revenue
- $2.5M
- Op. margin
- −956.5%
- FCF margin
- −0.1%
- Revenue
- $9.2M
- Op. margin
- −109.7%
- FCF margin
- —
- Revenue
- $1.9M
- Op. margin
- −465.4%
- FCF margin
- −219.9%
- Revenue
- $1.4B
- Op. margin
- 14.4%
- FCF margin
- 8.0%
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $0.8M
- Op. margin
- −2,190.0%
- FCF margin
- —
- Revenue
- $17.9B
- Op. margin
- −16.3%
- FCF margin
- −29.8%
- Revenue
- $3.0M
- Op. margin
- −88.0%
- FCF margin
- −56.8%
- Revenue
- $8.3M
- Op. margin
- −134.3%
- FCF margin
- −131.8%
- Revenue
- $18.9M
- Op. margin
- −32.3%
- FCF margin
- −10.1%
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $15.3M
- Op. margin
- −44.5%
- FCF margin
- —
- Revenue
- $0.0M
- Op. margin
- —
- FCF margin
- —
- Revenue
- $254M
- Net margin
- 24.2%
- FCF margin
- 31.5%
- Revenue
- $9.4M
- Op. margin
- −60.5%
- FCF margin
- —
- Revenue
- $0.1M
- Op. margin
- −16,726.7%
- FCF margin
- −10,171.9%
- Revenue
- $3.0M
- Op. margin
- −476.5%
- FCF margin
- —
- Revenue
- $7.7M
- Op. margin
- −70.4%
- FCF margin
- —
- Revenue
- $0.1M
- Op. margin
- −8,768.7%
- FCF margin
- −8,264.9%
- Revenue
- $307M
- Op. margin
- 4.5%
- FCF margin
- 2.1%
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $241M
- Op. margin
- 7.5%
- FCF margin
- 13.4%
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- —
- Op. margin
- —
- FCF margin
- —
- Revenue
- $7.4M
- Op. margin
- −400.1%
- FCF margin
- —
What do these columns mean?
- Market cap
- Last close times the latest diluted share count, so it is approximate.
- Price
- Closing share price on the last trading day.
- Day change
- Change in the closing price against the previous trading day's close.
- Revenue
- Total sales reported in the income statement.
- Revenue growth
- Change in revenue against the year (or quarter) a year earlier.
- Operating margin
- Operating income as a share of revenue.
- P/E
- Last close divided by diluted earnings per share over the last four quarters.
- 5-yr growth
- Revenue growth a year, compounded over the last five years.
- Gross margin
- Gross profit as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Free cash flow
- Cash from operations minus capital spending.
- FCF margin
- Free cash flow as a share of revenue.
- Return on capital
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
- Return on equity
- Net income as a share of average shareholders' equity.
- Net debt
- Debt and finance leases minus cash and short-term investments. Negative means net cash.
- Net debt / EBITDA
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Dividends + buybacks
- Cash returned to shareholders through dividends and share repurchases.
- Share count change
- Change in the diluted share count. Negative means buybacks shrank it.
- F-score
- Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
- Industry
- The industry the company reports under, from its SEC filing code. Click it to see its peers.
- Colours and dashes
- Green is up or growing, red is down or shrinking. — means no data, or a P/E that is not meaningful (losses, or above 200).
- Units
- M = millions, B = billions, T = trillions, in USD. Fundamentals use the latest fiscal year. Use “Edit columns” to show more figures, hide some or change their order.

















































